Last Price$68.62.5%
Market Cap$2,075.9M
$0.0
N/A
($33.0M)
+5.1% YoY
$0.0
Net Debt to FCF - N/A
$0.0
N/A
BLTE Income Statement
BLTE Income Statement Overview
Annual
Quarterly
LTM
Dec'20
Dec'21
Dec'22
Dec'23
BLTE Income statement key metrics
Annual
Quarterly
LTM
BLTE Balance Sheet
BLTE Balance Sheet Overview
Annual
Quarterly
LTM
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$94.6M
Current assets ($89.9M, 95.0% of total)
$88.2M (93.1%)
$867.0K (0.9%)
Other current assets
$916.0K (1.0%)
Non-current assets ($4,702.0K, 5.0% of total)
$0.0 (0.0%)
$1,301.0K (1.4%)
$3,235.0K (3.4%)
Other non-current assets
$166.0K (0.2%)
Financial position
($87.3M)
Cash & Short-term
Investments
Total Debt
BLTE Balance Sheet Metrics
Annual
Quarterly
LTM
BLTE Cash Flow Statement
BLTE Cash Flow Statement Overview
Annual
Quarterly
LTM
Dec'20
Dec'21
Dec'22
Dec'23
$46.1M Net Change in Cash
BLTE Cash Flow Statement key metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($29.8M) -100.0% YoY
Capital Expenditure (CAPEX)
($63.0K) -100.0% YoY
Free Cash Flow (FCF)
($29.9M) -100.0% YoY
BLTE Financials
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.2 | 0.4 |
% margin | (0.0) 0.0% | (0.0) 0.0% | (0.2) 0.0% | (0.4) 0.0% |
| Operating Expenses | 5.7 | 9.8 | 12.8 | 31.7 |
| Research & Development Expenses (R&D) | 3.7 | 7.4 | 8.9 | 24.8 |
| Selling, General & Administrative Expenses (SG&A) | 2.1 | 2.4 | 4.0 | 6.8 |
% margin | (5.7) 0.0% | (9.8) 0.0% | (12.8) 0.0% | (31.7) 0.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.1 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax Income | (5.8) | (9.7) | (12.6) | (31.6) |
% effective tax rate | 0.0 (0.0%) | 0.1 (1.3%) | (0.2) 1.4% | 0.0 (0.0%) |
% margin | (5.8) 0.0% | (9.8) 0.0% | (12.5) 0.0% | (31.6) 0.0% |
| EPS | (0.24) | (0.41) | (0.62) | (1.19) |
| Diluted EPS | (0.24) | (0.41) | (0.62) | (1.19) |
% margin | (5.7) 0.0% | (9.6) 0.0% | (12.4) 0.0% | (31.5) 0.0% |
FAQ
What is the Belite Bio, Inc (BLTE) revenue?
The Belite Bio, Inc (BLTE) revenue is $0.0, reflecting a year-over-year (YoY) growth of N/A.
What is the Belite Bio, Inc (BLTE) Net Income?
The Belite Bio, Inc (BLTE) Net Income is ($31.6M), showcasing a YoY growth of +153.6% YoY.
What is Belite Bio, Inc (BLTE) net debt?
What is the Belite Bio, Inc (BLTE) Free Cash Flow (FCF)?
The Belite Bio, Inc (BLTE) Free Cash Flow (FCF) stands at ($29.9M), accounting for a N/A margin.